Icardio.Ai

Company profile

About Icardio.Ai

iCardio.ai is a Los Angeles-based company pioneering the application of artificial intelligence to echocardiography and ultrasound interpretation. The company has developed a comprehensive suite of AI-powered tools designed to automate and enhance the analysis of cardiac ultrasound imaging. Leveraging a database of over 200 million individual echocardiographic images from hundreds of thousands of de-identified patients, iCardio.ai builds machine learning algorithms that address the significant challenges in cardiac imaging interpretation. The company's flagship products include EchoMeasure™, an FDA 510(k)-cleared solution that automates over a dozen standard cardiac measurements including ejection fraction, chamber dimensions, and wall thickness assessments. CardioVision™, which has received both FDA 510(k) clearance and FDA Breakthrough Device Designation, automatically detects aortic stenosis from parasternal long axis clips, addressing a critical diagnostic need in cardiovascular care. Additional tools include EchoCheck for image quality assessment, EchoGPT for image-to-text analysis, and various quantitative and qualitative interpretation modules. iCardio.ai partners with ultrasound equipment manufacturers and PACS providers to integrate its technology directly into clinical workflows. The company collaborates with world-leading cardiologists and AI scientists to create comprehensive automated analysis of echocardiograms at an unprecedented scale. Their solutions aim to reduce inter-reader variability, minimize work-related musculoskeletal disorders among sonographers, and ensure that critical conditions like aortic stenosis are never missed. The company serves health systems, cardiology practices, and imaging centers, with integrations available through major PACS systems including UltraLinQ.

Company description · Icardio.Ai official website